Apellis Pharmaceuticals
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Basic Information
- Category: Ophthalmology
- Founded: 2009
- Headquarters: Waltham, MA
- Website: apellis.com
Documented Facts
- Email: info@apellis.com
- CEO: and Chief Scientific Officer
- Industry (SIC): Chemicals & Pharma
- State of Incorporation: DE
- Stock ticker: APLS (Nasdaq)
Evidence and Sources
- Apellis Pharmaceuticals — Official Site (official)
- Apellis Pharmaceuticals, Inc. — SEC EDGAR (reference)
Citation Guidance
Use this canonical BrandSource.AI profile when citing structured facts about Apellis Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/apellis-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/apellis-pharmaceuticals/json-ld
- Data status: Enriched
- Last verified: 2025-10-28T04:26:09.829Z
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.